Features | Partner Sites | Information | LinkXpress
Sign In
ElsMed
Ampronix
Schiller

Hepatocellular Carcinoma Screening Linked with Curative Treatment and Longer Survival in Cirrhosis Patients

By Medimaging International staff writers
Posted on 24 Apr 2014
Image: Very high magnification micrograph of fibrolamellar hepatocellular carcinoma showing the characteristic laminated fibrosis between the tumor cells with a low N/C ratio. H&E stain (Photo courtesy of Wikimedia Commons).
Image: Very high magnification micrograph of fibrolamellar hepatocellular carcinoma showing the characteristic laminated fibrosis between the tumor cells with a low N/C ratio. H&E stain (Photo courtesy of Wikimedia Commons).
Investigators discovered that patients with cirrhosis who underwent surveillance (using liver ultrasound with or without measurement of serum alpha fetoprotein) for hepatocellular carcinoma (HCC) had cancers detected at an earlier stage, were more likely to receive curative instead of palliative treatment, and had longer survival.

In a systematic review and meta-analysis of 47 studies with 15,158 patients, Dr. Amit Singal, from the University of Texas Southwestern Medical Center (Dallas, USA) and colleagues reported that the pooled thee-year survival rate across all the studies was 50.8% among the 4,735 patients who underwent HCC surveillance, compared to 27.9% among the 6,115 patients without earlier surveillance (p < 0.001).

The finding of longer survival persisted after the authors limited their review to studies that took into account lead time bias. Lead time bias, as it applies to this study, is the time between when a disease would normally be diagnosed without screening and when the disease is diagnosed with screening. Detecting disease earlier through screening can at times seen be to increase survival when instead it only prolongs the time the person has the diagnosis. However, in this case, studies that accounted for lead time bias statistically still found that screening increased survival. Among the six studies that adjusted for lead time bias, those who underwent HCC surveillance had three-year survival rates of 39.7%, vs. 29.1% among those who did not (p < 0.001).

The authors noted that while screening for HCC in patients with Hepatitis B virus (HBV) infection is supported by a large randomized trial, no such randomized trials exist for patients with cirrhosis. Therefore the authors systematically reviewed published research that evaluated whether screening was associated with improved patient outcomes. While guidelines of the American Association for the Study of Liver Diseases and European Association for the Study of the Liver recommend monitoring with ultrasound every six months in high-risk patients (which includes those with chronic HBV infection and/or cirrhosis), the authors noted that studies have shown that surveillance in the United States is performed in less than 20% of these patients nationally, with lower rates among primary care physicians than gastroenterologists/hepatologists (physicians who specialize in caring for patients with liver disease).

A drawback of the study is that the studies were quite heterogeneous, suggesting benefits of surveillance may not be uniform among all patients, and studies did not include functional status, an important factor in determining appropriate treatment.

The authors concluded that, “the preponderance of data that consistently demonstrate benefits should provide sufficient rationale to recommend HCC surveillance, even in the absence of a randomized controlled trial among patients with cirrhosis.”

Related Links:

University of Texas Southwestern Medical Center



Channels

Radiography

view channel

Program Devised to Supply Radiology Departments with Advanced Digital Radiography Systems

A program is designed to provide hospitals an avenue to upgrade their technology, while maximizing their existing investment. The program includes novel solutions to keep systems and technology up-to-date. Program allows imaging facilities to advance at their speed and budget from computed radiography (CR) using conventional... Read more

MRI

view channel
Image: Patients in a vegetative state had brain activity levels matching those of healthy controls while watching a Hitchcock film (Photo courtesy of Western University’s Lorina Naci).

Neuroscientists Differentiate Patients in Ongoing Vegetative State

Researchers are employing advanced brain scanning techniques by showing that a short movie can be used to detect consciousness in vegetative state patients. The study included a Canadian participant... Read more

Nuclear medicine

view channel

PET-CT Imaging Forecasts Survival of Lymphoma Better Than Standard Imaging Strategies

Positron emission tomography-computed tomography (PET-CT) imaging is more accurate than traditional CT scanning in gauging response to treatment and predicting survival in patients with follicular lymphoma, and should be used routinely in clinical practice. The findings were published September 18, 2014, in the journal... Read more

General/Advanced Imaging

view channel

New Imaging Technology Shows Little Discrepancy Between Breast Cancer, Healthy Tissues

A new application has been effectively evaluated that will help surgeons better differentiate cancerous breast tissue from normal tissue, thereby decreasing the likelihood for repeat operations. The tool, called DESI (desorption electrospray ionization) mass spectrometry imaging, works by converting molecules into electrically... Read more

Imaging IT

view channel

Software Provides Enhanced Imaging Sharing Capabilities and Connection Consistency in the Case of Network Failure

Members of the physician information technology (IT) group at a US radiology practice are utilizing a new software technology to enhance its image sharing capabilities and provide immediate cluster failover in case of network failures. The Dicom Systems’ (Campbell, CA, USA) enterprise imaging solutions will be utilized... Read more

Industry News

view channel

Global Partnership Provides Treatment Planning Support for Modulated Arc Radiotherapy

Varian Medical Systems (Palo Alto, CA, USA) Eclipse treatment planning software can now be used to plan modulated arc radiotherapy (mARC) treatments at sites using Siemens Healthcare (Erlangen, Germany) medical linear accelerators. Varian Medical Systems and Siemens Healthcare presented their range of solutions that... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.